The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Calliditas Therapeutics AB - ADR(NASDAQ:CALT) 
Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a unique formulation optimized to...
Website: https://www.calliditas.se/
Founded: 2004
Full Time Employees: 23
CEO: Renée Julie Elisabet Aguiar-Lucander
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Share this website to your friends
Calliditas Therapeutics AB - ADR Days Payable Outstanding ttm (DPO)
Calliditas Therapeutics AB - ADR Days Receivable Outstanding ttm (DSO)
Calliditas Therapeutics AB - ADR Days Inventory Outstanding ttm (DIO)
Calliditas Therapeutics AB - ADR Op Cashflow Per Share ttm
Calliditas Therapeutics AB - ADR Free Cashflow Per Share ttm
Calliditas Therapeutics AB - ADR Cash Per Share ttm
Calliditas Therapeutics AB - ADR P/S ratio ttm
Calliditas Therapeutics AB - ADR (GAAP) P/E ratio ttm
Calliditas Therapeutics AB - ADR P/B ratio ttm
No extra charts and metrics for this ticker.